How to use imaging endpoints reflecting the pulmonary circulation & RV
16 June 2025
References and notes
Presented at PVRI's Drug Discovery & Development Symposium 2025, David Kiely, University of Sheffield
Summary
Imaging is essential in pulmonary hypertension, acting as a surrogate endpoint in clinical trials. It highlights the importance of right ventricular function and showcases various imaging techniques with predictive capabilities. CMR imaging stands out as a promising marker, while new technologies like perfusion imaging and hyper-polarised gases provide fresh insights. The integration of AI aims to improve clinical outcomes, emphasising the need for collaboration in future studies.